| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/07/2005 | EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor |
| 09/07/2005 | EP1570851A1 Skin material for external use and antiprutiric agent for external use and wrinkle-reducing instrument using the same |
| 09/07/2005 | EP1570850A1 Topical formulations for treatment of rosacea |
| 09/07/2005 | EP1570840A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 09/07/2005 | EP1570839A1 Composition for preparation for external use on skin and method of using the same |
| 09/07/2005 | EP1570069A2 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 09/07/2005 | EP1569928A1 Therapeutic compounds and methods |
| 09/07/2005 | EP1569907A1 Nicotinamide-based kinase inhibitors |
| 09/07/2005 | EP1569724A1 Formulations containing melatonin, ginkgo biloba, and biotin |
| 09/07/2005 | EP1569697A1 Wound dressings comprising vanadate complexed with organic ligands |
| 09/07/2005 | EP1569672A1 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside |
| 09/07/2005 | EP1569668A1 An organic extract of geum japonicum thumb variant and use thereof |
| 09/07/2005 | EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 09/07/2005 | EP1569612A1 Novel topical use of bis-arylimidazo 1,2-a thiolane derivatives |
| 09/07/2005 | EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 09/07/2005 | EP1458717B1 Aroyl pyridinones |
| 09/07/2005 | EP1447094A9 Remedies for pruritus |
| 09/07/2005 | EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/07/2005 | EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/07/2005 | EP1370279B1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 09/07/2005 | EP1335740B1 Preparations having effect against allergic symptoms and their manufacturing method |
| 09/07/2005 | EP1328519B1 Orally active salts with tyrosine kinase activity |
| 09/07/2005 | EP1307438B1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 09/07/2005 | EP1299430B1 Process for preparing benzoxazin-4-one polymer conjugates |
| 09/07/2005 | EP0981326B1 Personal cleansing compositions |
| 09/07/2005 | EP0973532B1 Anti-proliferative preparations |
| 09/07/2005 | CN1665925A Factor VII or VIIa polypeptide variants |
| 09/07/2005 | CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 09/07/2005 | CN1665829A Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 09/07/2005 | CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665809A Azaindoles |
| 09/07/2005 | CN1665807A Novel physiolgically active substances |
| 09/07/2005 | CN1665804A 4, 4-disubstituted piperidine derivatives having CCR3 antagonism |
| 09/07/2005 | CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665764A An hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665535A Perylenequinones for use with immunotherapy agents |
| 09/07/2005 | CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/07/2005 | CN1665519A Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 09/07/2005 | CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665510A Cyclothiocarbamative derivatives as PR modulators and use thereof for treatment of skin disorders |
| 09/07/2005 | CN1665507A Therapeutic 1, 2, 3, 6-tetrahydropyrimidine-2-one compositions and methods therewith |
| 09/07/2005 | CN1665488A Direct cellular energy delivery system |
| 09/07/2005 | CN1665476A Method and composition for improving sensory characteristics of semisolid predominantly anhydrous |
| 09/07/2005 | CN1663593A Glucoside active site LWD-b in Liuwei Dihuang decoction, its preparation and medical usage |
| 09/07/2005 | CN1663583A Externally applied medicine for treating acute soft tissue injury |
| 09/07/2005 | CN1663559A Skin normalizing agents |
| 09/07/2005 | CN1663556A Externally applied drug/cosmetic for inhibiting alopeia or/and promoting hair regeneration |
| 09/07/2005 | CN1663555A Externally applied drug or/and cosmetic for inhibiting alopeia or/and promoting hair regeneration |
| 09/07/2005 | CN1217926C Novel vitamin D analogues |
| 09/07/2005 | CN1217918C Aminocyclohexyl ether compounds and uses thereof |
| 09/07/2005 | CN1217696C Health caring and face nursing composition of natural materials |
| 09/07/2005 | CN1217693C Ointment for curing scald and its preparation method |
| 09/07/2005 | CN1217674C Snuff pill for treating TB and ulcer |
| 09/07/2005 | CN1217664C Use of 2-methylene-19-Nor-20(s)-1 alpha, 25-dihydroxy vitamin D3 to increase bone strength |
| 09/07/2005 | CN1217660C IL-8 receptor antagonists |
| 09/07/2005 | CN1217652C Cosmetic method of treating skin |
| 09/07/2005 | CN1217651C Skin care compositions containing cis-9, trans-11 linoleic acid |
| 09/07/2005 | CN1217644C Beauty and skin composition containing plant extract |
| 09/06/2005 | US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 09/06/2005 | US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 09/06/2005 | US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 09/06/2005 | US6939872 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 09/06/2005 | US6939868 Anticancer agents; skin disorders; bone disorders |
| 09/06/2005 | US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
| 09/06/2005 | US6939859 Skin preparations for external use |
| 09/06/2005 | US6939568 Hydrated dressing containing metal microbiocide |
| 09/06/2005 | US6939376 Drug-delivery endovascular stent and method for treating restenosis |
| 09/06/2005 | CA2179778C Deuterised active agents in transdermal application |
| 09/06/2005 | CA2119516C Ointment for wound treatment |
| 09/06/2005 | CA2105652C Reducing wound scarring with antibodies to growth factors |
| 09/04/2005 | CA2491341A1 Topical formulations for treatment of rosacea |
| 09/01/2005 | WO2005080553A1 Cell-associated physiologically active substance and cell culture supplement |
| 09/01/2005 | WO2005080385A1 Indanol derivative |
| 09/01/2005 | WO2005079818A1 Glycerol solution containing dissolved ozone, solidified glycerol containing dissolved ozone, mixed solution containing dissolved ozone, process for producing glycerol solution containing dissolved ozone, process for producing mixed solution containing dissolved ozone, and method of storing glycerol solution containing diss |
| 09/01/2005 | WO2005079788A1 Amino alcohol compound |
| 09/01/2005 | WO2005079770A2 Use of a compound modulating at least one receiver selected in a group comprising an interleukin 8 type b receptor and pacap-1 receptor for preparing a pharmaceutical composition for rosacea treatment |
| 09/01/2005 | WO2005037772A3 Novel ligand activating receptors rars used for human medicine and cosmetics |
| 09/01/2005 | WO2005034839A3 Porifera-based therapeutic compositions for treating and preventing skin diseases |
| 09/01/2005 | WO2004048512A3 Novel proteins and nucleic acids encoding same |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050192350 Aspirin-triggered lipoxins as modulators of diseases associated with polymorphoneutrophil inflammation; antiinflammatory agents |
| 09/01/2005 | US20050192336 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 09/01/2005 | US20050192306 Pyrimidine derivatives as selective inhibitors of COX-2 |
| 09/01/2005 | US20050192284 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use |
| 09/01/2005 | US20050192238 Modulation of the expression of genes dependent on stat-1 |
| 09/01/2005 | US20050192217 Utilization of lipopeptides or lipoproteins in wound treatment and infection prophylaxis |
| 09/01/2005 | US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation |
| 09/01/2005 | US20050191370 Combination elicites an antioxidant effect, increase the mean diameter of the strands of hair, decrease the heterogeneity of the diameters of the hairs and increase hair density, thus reflecting regrowth |
| 09/01/2005 | US20050191354 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 09/01/2005 | US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 09/01/2005 | US20050191268 Polyphenol-and protein-containing extracts of winemaking residues, and methods of using the same |
| 09/01/2005 | US20050191267 Mulberry extract; whitening effects for darkened skin through antityrosinase activity, antioxidant and anti-inflammatory properties |
| 09/01/2005 | US20050191266 Prophylaxis or treatment of inflammatory skin conditions |
| 09/01/2005 | DE102004009152A1 Using ascorbic acid and its derivatives for treating teleangiektasia and vascular slackness, and for tightening superficial blood vessels |
| 09/01/2005 | DE102004005788A1 Zubereitungen enthaltend Echinacea-Auszüge und Thiocyanat Preparations containing Echinacea extracts and thiocyanate |
| 09/01/2005 | CA2557837A1 Fructoseamine 3 kinase and the formation of collagen and elastin |
| 09/01/2005 | CA2557539A1 Indanol derivative |